208 related articles for article (PubMed ID: 32792953)
21. A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep.
Organ L; Bacci B; Koumoundouros E; Barcham G; Kimpton W; Nowell CJ; Samuel C; Snibson K
Exp Lung Res; 2015 Apr; 41(3):115-34. PubMed ID: 25531791
[TBL] [Abstract][Full Text] [Related]
22. SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis.
Vizier R; Garnier AR; Dias A; Moreau M; Claron M; Collin B; Denat F; Bellaye PS; Goncalves V
Mol Pharm; 2023 Jul; 20(7):3613-3622. PubMed ID: 37307296
[TBL] [Abstract][Full Text] [Related]
23. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
24. Inhaled nintedanib is well-tolerated and delivers key pharmacokinetic parameters required to treat bleomycin-induced pulmonary fibrosis.
Surber MW; Beck S; Pham S; Marsden AT; Gandi SK; Baily J; McElroy MC
Pulm Pharmacol Ther; 2020 Aug; 63():101938. PubMed ID: 32841676
[TBL] [Abstract][Full Text] [Related]
25. Development of a non-infectious rat model of acute exacerbation of idiopathic pulmonary fibrosis.
Chen SS; Yin ZF; Chen T; Qiu H; Wei YR; Du SS; Jin YP; Zhao MM; Wu Q; Weng D; Li HP
J Thorac Dis; 2017 Jan; 9(1):96-105. PubMed ID: 28203411
[TBL] [Abstract][Full Text] [Related]
26. Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis.
Wang M; Liu AD; Niu Q; Feng X; Zheng YY; Chen SJ; Xu H; Li Q; Hou GQ; Bi XY; Lu YZ; Cheng PP; Liang LM; Jiang YH; Zhao LQ; Liu F; Song LJ; Zhou LL; Xiao LY; Chen F; Li SS; Ma WL; Cao X; Ye H
Theranostics; 2022; 12(10):4513-4535. PubMed ID: 35832075
[No Abstract] [Full Text] [Related]
27. The Bleomycin Model of Pulmonary Fibrosis.
Liu T; De Los Santos FG; Phan SH
Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
[TBL] [Abstract][Full Text] [Related]
28. In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach.
Mecozzi L; Mambrini M; Ruscitti F; Ferrini E; Ciccimarra R; Ravanetti F; Sverzellati N; Silva M; Ruffini L; Belenkov S; Civelli M; Villetti G; Stellari FF
Sci Rep; 2020 Oct; 10(1):18735. PubMed ID: 33127949
[TBL] [Abstract][Full Text] [Related]
29. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
[TBL] [Abstract][Full Text] [Related]
30. A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice.
Ruscitti F; Ravanetti F; Donofrio G; Ridwan Y; van Heijningen P; Essers J; Villetti G; Cacchioli A; Vos W; Stellari FF
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708527
[TBL] [Abstract][Full Text] [Related]
31. A New Model of Acute Exacerbation of Experimental Pulmonary Fibrosis in Mice.
Yegen CH; Haine L; Da Costa Ferreira K; Marchant D; Bernaudin JF; Planès C; Voituron N; Boncoeur E
Cells; 2022 Oct; 11(21):. PubMed ID: 36359778
[TBL] [Abstract][Full Text] [Related]
32. Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model.
Principi L; Ferrini E; Ciccimarra R; Pagani L; Chinello C; Previtali P; Smith A; Villetti G; Zoboli M; Ravanetti F; Stellari FF; Magni F; Piga I
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901840
[TBL] [Abstract][Full Text] [Related]
33. Nintedanib for the treatment of idiopathic pulmonary fibrosis.
Varone F; Sgalla G; Iovene B; Bruni T; Richeldi L
Expert Opin Pharmacother; 2018 Feb; 19(2):167-175. PubMed ID: 29327616
[TBL] [Abstract][Full Text] [Related]
34. Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib-hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis.
Togami K; Ogasawara A; Irie S; Iwata K; Yamaguchi K; Tada H; Chono S
Eur J Pharm Biopharm; 2022 Mar; 172():203-212. PubMed ID: 35183716
[TBL] [Abstract][Full Text] [Related]
35. Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice.
Kishi M; Aono Y; Sato S; Koyama K; Azuma M; Abe S; Kawano H; Kishi J; Toyoda Y; Okazaki H; Ogawa H; Uehara H; Nishioka Y
PLoS One; 2018; 13(12):e0209786. PubMed ID: 30596712
[TBL] [Abstract][Full Text] [Related]
36. Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Arora A; Bhuria V; Hazari PP; Pathak U; Mathur S; Roy BG; Sandhir R; Soni R; Dwarakanath BS; Bhatt AN
Front Pharmacol; 2018; 9():394. PubMed ID: 29740320
[TBL] [Abstract][Full Text] [Related]
37. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
38. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis.
Organ L; Bacci B; Koumoundouros E; Barcham G; Milne M; Kimpton W; Samuel C; Snibson K
BMC Pulm Med; 2015 Jul; 15():81. PubMed ID: 26227819
[TBL] [Abstract][Full Text] [Related]
39. Intratracheal Bleomycin Aerosolization: The Best Route of Administration for a Scalable and Homogeneous Pulmonary Fibrosis Rat Model?
Robbe A; Tassin A; Carpentier J; Declèves AE; Mekinda Ngono ZL; Nonclercq D; Legrand A
Biomed Res Int; 2015; 2015():198418. PubMed ID: 26064885
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis.
Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M
Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
